Victrex Share News (VCT)
VCT Share
VCT Share
VCT Share
VCT Share
VCT
VCT Share
VCT Level 2
VCT Live
VCT Broker
VCT Directors
VCT Financial
VCT
VCT Short
VCT
Last checked at -
Thu, 21st Oct 2021 10:48
Victrex PLC - Blackpool, England-based supplier of polymers - Reports its commitment to the science based target initiative, in addition to its 2030 carbon net zero goal. As part of its commitment, Victrex joins the business ambition for 1.5C campaign to help to halve global emissions.
Current FTSE 250 stock price: 2,346.00 pence
Year-to-date change: unchanged
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Sharecast News) - Workspace Group: Berenberg downgrades to sell with a target price of 670p.
Read more(Sharecast News) - Barclays upgraded Victrex to 'equalweight' from 'underweight' on Thursday, hiking the price target to 1,980p from 1,710p, arguing that Croda is a better 'underweight' idea.
Read moreUK BROKER RATINGS SUMMARY: JPMorgan Raises Man Group And Sanne
Read moreLONDON BRIEFING: Ocado Retail Says Coping With "Exceptional Demand"
Read moreVictrex Reports Resilient Financial Position Despite Covid-19 Impact
Read more(Sharecast News) - Polymer company Victrex reported a 7% fall in full-year sales volumes on Wednesday, while revenue fell 10% to £266m, with the company saying it was impacted by end-market weakness in the second half.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read more(Sharecast News) - Diageo: Deutsche Bank upgrades to buy with a target price of 3,900p.
Read moreUK BROKER RATINGS SUMMARY: Goldman Sachs Raises easyJet, Cuts Wizz Air
Read moreUK BROKER RATINGS SUMMARY: Analysts Positive On The Hut Group
Read moreUK BROKER RATINGS SUMMARY: Citi Upgrades FirstGroup, National Express
Read moreLONDON MARKET CLOSE: Housebuilders Push FTSE 100 To Close Higher
Read moreVictrex Annual Revenue Falls On Lower Output, To Resume Dividends
Read more(Sharecast News) - Victrex guided towards slightly better-than-expected sales for the financial year ending on 30 September and told shareholders to expect its dividend to be reinstated.
Read more(Sharecast News) - Dechra Pharmaceuticals: Liberum initiates at sell with a target price of 2,740p.
Read more
Last checked at